Recent progress of 4D printing in cancer therapeutics studies

Atchara Chinnakorn1, Wiwat Nuansing1, Mahdi Bodaghi2

  • 1School of Physics, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.

SLAS Technology
|February 21, 2023
PubMed

Insights

Four-dimensional (4D) printing, an advanced fabrication technique, shows promise for novel cancer therapeutics. This review explores its mechanisms and applications in cancer management, paving the way for future innovations.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Cancer remains a leading global cause of mortality, necessitating advancements in prognosis, diagnosis, and treatment.
  • Post-treatment monitoring, including postsurgical and chemotherapeutical effects, is crucial for patient outcomes.
  • Current cancer therapeutic strategies require continuous innovation to improve efficacy and patient care.

Approach:

  • This review introduces four-dimensional (4D) printing as a next-generation fabrication technique for dynamic constructs.
  • It details the mechanisms enabling programmable shapes, controllable locomotion, and on-demand functions in 4D-printed materials.
  • The study focuses on the initial applications and potential of 4D printing in cancer therapeutics.

Key Points:

  • 4D printing enables the creation of dynamic and responsive materials for targeted cancer therapies.
  • Mechanisms for inducing shape-changing and functional behaviors in 4D constructs are explored.
  • The review highlights recent advancements and potential applications of 4D printing in various aspects of cancer treatment.

Conclusions:

  • 4D printing technology is in its nascent stages for cancer applications, requiring further research and development.
  • This technology offers a promising avenue for developing innovative and personalized cancer therapeutics.
  • Future perspectives suggest significant potential for 4D printing to revolutionize cancer management and treatment strategies.